Member Exclusive

RIBOTACs – targeting RNA to tackle genetic malignancies

Researchers at The Scripps Research Institute have used small molecules to help catalyze the breakdown of harmful RNA strands, with diseases such as cancer in their sights.

Go to the profile of Benjamin Walden
May 31, 2018

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.